网站主页 > 化工产品目录 > 生物化工 > 抑制剂 > 细胞周期(Cell Cycle) > Aurora Kinase 抑制剂 > GSK1070916

GSK1070916

GSK1070916 更多供应商
公司名称:上海波以尔化工有限公司  
联系电话:86-15221043597
产品介绍:中文名称:N'-[4-[4-[2-[3-[(二甲基氨基)甲基]苯基]-1H-吡咯并[2,3-B]吡啶-4-基]-1-乙基-1H-吡唑-3-基]苯基]-N,N-二甲基脲
英文名称:N'-4-4-2-3-(Dimethylamino)methylphenyl-1H-pyrrolo2,3-bpyridin-4-yl-1-ethyl-1H-pyrazol-3-ylphenyl-N,N-dimethylurea
CAS:942918-07-2
公司名称:上海佰世凯化学科技有限公司  
联系电话:+86(0)21-20908456
产品介绍:英文名称:GSK 1070916
CAS:942918-07-2
备注:C14668
公司名称:上海景颜化工科技有限公司  
联系电话:13817811078,021-50426030
产品介绍:英文名称:GSK1070916
纯度:98%
公司名称:凯方医药科技(上海)有限公司  
联系电话:021-67220633 & 021-37212706
产品介绍:英文名称:3-(4-(4-(2-(3-((DiMethylaMino)Methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-diMethylurea
CAS:942918-07-2
纯度:99% 包装信息:5KG;1KG
公司名称:武汉永璨生物科技有限公司  
联系电话:0086-27-5925 3327; QQ:40199614
产品介绍:英文名称:GSK1070916
CAS:942918-07-2
纯度:98% 包装信息:1g,5g,10g,50g 备注:only used for research
GSK1070916
生物活性 体外研究 体内研究
中文名称:GSK1070916
中文同义词:N'-[4-[4-[2-[3-[(二甲基氨基)甲基]苯基]-1H-吡咯并[2,3-B]吡啶-4-基]-1-乙基-1H-吡唑-3-基]苯基]-N,N-二甲基脲
英文名称:GSK1070916
英文同义词:N'-[4-[4-[2-[3-[(Dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethylurea;GSK1070916;3-(4-(4-(2-(3-((Dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea;N'-[4-[4-[2-[3-[(DiMethylaMino)Methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl;GSK-1070916A
CAS号:942918-07-2
分子式:C30H33N7O
分子量:507.63
EINECS号:
相关类别:Inhibitor;Inhibitors;小分子抑制剂,天然产物
Mol文件:942918-07-2.mol
GSK1070916
GSK1070916 性质
密度 1.21
GSK1070916 用途与合成方法
生物活性GSK1070916是一种可逆的,ATP竞争性的Aurora B/C抑制剂,IC50为3.5 nM/6.5 nM,比作用于紧密相关的Aurora A-TPX2复合体选择性高100倍以上。 Phase 1。
体外研究GSK1070916 selectively inhibits Aurora B and Aurora C with Ki of 0.38 nM and 1.5 nM over Aurora A with Ki of 490 nM. Inhibition of Aurora B and Aurora C is time-dependent, with an enzyme-inhibitor dissociation half-life of >480 min and 270 min respectively. In addition, GSK1070916 is also a competitive inhibitor with respect to ATP. Human tumor cells treated with GSK1070916 shows dose-dependent inhibition of phosphorylation on serine 10 of Histone H3, a substrate specific for Aurora B. Moreover, GSK1070916 inhibits the proliferation of tumor cells with EC50 values of <10 nM in over 100 cell lines spanning a broad range of tumor types, with a median EC50 of 8 nM. Although GSK1070916 has potent activity against proliferating cells, a dramatic shift in potency is observed in primary, nondividing, normal human vein endothelial cells. Furthermore, GSK1070916-treated cells do not arrest in mitosis but instead fails to divide and become polyploid, ultimately leading to apoptosis. In another study, it is also reported high chromosome number associated with resistance to the inhibition of Aurora B and C suggests cells with a mechanism to bypass the high ploidy checkpoint are resistant to GSK1070916.
体内研究GSK1070916 (25, 50, or 100 mg/kg) shows dose-dependent inhibition of phosphorylation of an Aurora B–specific substrate in mice and consistent with its broad cellular activity, has antitumor effects in 10 human tumor xenograft models including breast, colon, lung, and two leukemia models.
安全信息
"GSK1070916" 相关产品信息
Enzastaurin (LY317615) ZM 447439 MK-5108 (VX-689) Alisertib (MLN8237) Veliparib (ABT-888) Barasertib (AZD1152-HQPA)